Impaired HDL antioxidant and anti-inflammatory functions are linked to increased mortality in acute heart failure patients.

In patients with AHF, impaired HDL CEC, HDL antioxidant and anti-inflammatory function, and impaired HDL metabolism are associated with increased mortality. Assessment of HDL function and subclass distribution could provide valuable clinical information and help identify patients at high risk.